Melanie Dunstan
I joined Professor Holm Uhlig’s group and the Diabetes and Inflammation Laboratory (Professor John Todd and Professor Linda Wicker) in 2017 as an Oxford-Bristol Myers Squibb (formerly Celgene) Fellow. My research is focused on single-cell analysis of gut-resident T cells in health and disease.
Using the BD Rhapsody™ and BD™ AbSeq platform, we have simultaneously quantified the expression of 405 genes at the mRNA level and 79 genes at the protein level in CD45+ cells isolated from the blood (n=61,000) and small intestine (n=92,000) of 15 paediatric patients with either type 1 Diabetes and coeliac disease (n=4); coeliac disease alone (n=6); or with no disease pathology (n=5).
This study has identified several putative disease-associated cell populations. I am currently working on the functional characterisation and validation of these novel populations.
Recent publications
Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis
Journal article
Trzupek D. et al, (2020), Genome Medicine, 12
Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study
Journal article
Prins BP. et al, (2016), PLOS Medicine, 13, e1001976 - e1001976
Shared genetic contribution to ischemic stroke and Alzheimer's disease
Journal article
Traylor M. et al, (2016), Annals of Neurology, 79, 739 - 747
A novel Alzheimer disease locus located near the gene encoding tau protein
Journal article
Jun G. et al, (2016), Molecular Psychiatry, 21, 108 - 117
Convergent genetic and expression data implicate immunity in Alzheimer's disease
Journal article
Jones L. et al, (2015), Alzheimer's & Dementia, 11, 658 - 671
